MOSAIQ Oncology Information System with Particle Therapy License (License Kit 45700000000IQRO)
Published January 21, 2026 · Recall initiated: December 10, 2025
Summary
FDA records medical device Class II recall Z-1078-2026, published January 21, 2026 and initiated December 10, 2025. Recalling firm: Elekta, Inc.; Status: Ongoing; Reported quantity: 1; Lot: MOSAIQ v 3.10.200, and 3.1.1.0 up to and including v 3.2.3.1 with Particle Base. Software Versions: 3.10.200, 3.1.1.0, 3.1.2.0, 3.1.3.0, 3.1.3.1, 3.1.3.2, 3.1.3.3, 3.1.3.4, 3.2.0.0, 3.2.1.0, 3.2.1.1, 3.2.1.2, 3.2.1.3, 3.2.1.4, 3.2.2.0, 3.2.2.1, 3.2.3.0, 3.2.3.1 UDI-DI: 07340201500026, 07340201500071. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Using oncology information system that manages workflow may result in overtreatment if:Plan delivered with Particle Therapy IHE-RO TDW-II interface,With one field per fraction or last field partial treatment,Partial treatment occurs followed by treatment field interruptions with manually recorded partial treatment,Then treatment unit doesn't check meterset value so partial treatment delivered twice
What to do
Voluntary: Firm initiated
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Elekta, Inc.
- Distributor
- US Nationwide distribution in the state of TX.
- Lot
- MOSAIQ v 3.10.200, and 3.1.1.0 up to and including v 3.2.3.1 with Particle Base. Software Versions: 3.10.200, 3.1.1.0, 3.1.2.0, 3.1.3.0, 3.1.3.1, 3.1.3.2, 3.1.3.3, 3.1.3.4, 3.2.0.0, 3.2.1.0, 3.2.1.1, 3.2.1.2, 3.2.1.3, 3.2.1.4, 3.2.2.0, 3.2.2.1, 3.2.3.0, 3.2.3.1 UDI-DI: 07340201500026, 07340201500071
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDABrand Name: Geneva Product Name: Brachytherapy Applicator Product Description: The device is intended forJuly 15, 2026
- FDABrand Name: Fletcher CT/MR Shielded Applicator Set Product Name: Intracavitary Remote Afterloading ApplicatorJuly 15, 2026
- FDABrand Name: Brachytherapy Applicator Product Name: Advanced Gynecological Applicator Product Description: TheJuly 15, 2026
- FDAMOSAIQ Oncology Information SystemJune 17, 2026
- FDABD Ready-to-Use Hydrophilic Catheter 14 Fr (4.7 mm) Straight Tip, Coated, Female REF: RTU14FJanuary 21, 2026
- FDAMedline medical procedure convenience kits labeled as: KIT ROBOTICS UROLOGY PROSTATE, REF DYKMBNDL116GJanuary 21, 2026
Questions about this recall
Was MOSAIQ Oncology Information System with Particle Therapy License (License Kit 45700000000IQRO) recalled?
Yes. FDA published recall Z-1078-2026 on January 21, 2026. Reported hazard: Using oncology information system that manages workflow may result in overtreatment if:Plan delivered with Particle Therapy IHE-RO TDW-II interface,With one field per fraction or last field partial treatment,Partial treatment occurs followed by treatment field interruptions with manually recorded partial treatment,Then treatment unit doesn't check meterset value so partial treatment delivered twice
What should I do if I have this product?
Voluntary: Firm initiated